Literature DB >> 18022678

Estrogen receptors: their roles in regulation of vasopressin release for maintenance of fluid and electrolyte homeostasis.

Celia D Sladek1, Suwit J Somponpun.   

Abstract

Long standing interest in the impact of gonadal steroid hormones on fluid and electrolyte balance has led to a body of literature filled with conflicting reports about gender differences, the effects of gonadectomy, hormone replacement, and reproductive cycles on plasma vasopressin (VP), VP secretion, and VP gene expression. This reflects the complexity of gonadal steroid hormone actions in the body resulting from multiple sites of action that impact fluid and electrolyte balance (e.g. VP target organs, afferent pathways regulating the VP neurons, and the VP secreting neurons themselves). It also reflects involvement of multiple types of estrogen receptors (ER) in these diverse sites including ERs that act as transcription factors regulating gene expression (i.e. the classic ERalpha as well as the more recently discovered ERbeta) and potentially G-protein coupled, membrane localized ERs that mediate rapid non-genomic actions of estrogen. Furthermore, altered expression of these receptors in physiologically diverse conditions of fluid and electrolyte balance contributes to the difficulty of using simplistic approaches such as gender comparisons, gonadectomy, and hormone replacement to assess the role of gonadal steroids in regulation of VP secretion for maintenance of fluid and electrolyte homeostasis. This review catalogs these inconsistencies and provides a frame work for understanding them by describing: (1) the effect of gonadal steroids on target organ responsiveness to VP; (2) the expression of multiple types of estrogen receptors in the VP neurons and in brain regions monitoring feedback signals from the periphery; and (3) the impact of dehydration and hyponatremia on expression of these receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18022678      PMCID: PMC2274006          DOI: 10.1016/j.yfrne.2007.08.005

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  106 in total

Review 1.  Genomic and nongenomic effects of estrogen in the vasculature.

Authors:  Michael E Mendelsohn
Journal:  Am J Cardiol       Date:  2002-07-03       Impact factor: 2.778

2.  Changes in the arginine-vasopressin immunoreactive systems in male mice lacking a functional aromatase gene.

Authors:  L Plumari; C Viglietti-Panzica; F Allieri; S Honda; N Harada; P Absil; J Balthazart; G C Panzica
Journal:  J Neuroendocrinol       Date:  2002-12       Impact factor: 3.627

Review 3.  Estrogen modulates oxytocin gene expression in regions of the rat supraoptic and paraventricular nuclei that contain estrogen receptor-beta.

Authors:  Paul J Shughrue; Tammy L Dellovade; István Merchenthaler
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

4.  Oestradiol-dependent and -independent modulation of tyrosine hydroxylase mRNA levels in subpopulations of A1 and A2 neurones with oestrogen receptor (ER)alpha and ER beta gene expression.

Authors:  M A Curran-Rauhut; S L Petersen
Journal:  J Neuroendocrinol       Date:  2003-03       Impact factor: 3.627

5.  Estrogen receptor-beta regulates transcript levels for oxytocin and arginine vasopressin in the hypothalamic paraventricular nucleus of male mice.

Authors:  Masayoshi Nomura; Elizabeth McKenna; Kenneth S Korach; Donald W Pfaff; Sonoko Ogawa
Journal:  Brain Res Mol Brain Res       Date:  2002-12-30

6.  Global transcription profiling of estrogen activity: estrogen receptor alpha regulates gene expression in the kidney.

Authors:  Scott A Jelinsky; Heather A Harris; Eugene L Brown; Kathryn Flanagan; Xiaochun Zhang; Christopher Tunkey; KehDih Lai; Malcolm V Lane; Donna K Simcoe; Mark J Evans
Journal:  Endocrinology       Date:  2003-02       Impact factor: 4.736

7.  Role of estrogen receptor-beta in regulation of vasopressin and oxytocin release in vitro.

Authors:  Suwit Somponpun; Celia D Sladek
Journal:  Endocrinology       Date:  2002-08       Impact factor: 4.736

8.  Pseudo-symmetry of C19 steroids, alternative binding orientations, and multispecificity in human estrogenic 17beta-hydroxysteroid dehydrogenase.

Authors:  Anne Gangloff; Rong Shi; Virginie Nahoum; Sheng-Xiang Lin
Journal:  FASEB J       Date:  2002-12-17       Impact factor: 5.191

9.  Estrogen receptor beta messenger ribonucleic acid expression in the forebrain of proestrous, pregnant, and lactating female rats.

Authors:  Béatrice Gréco; Laura S Lubbers; Jeffrey D Blaustein
Journal:  Endocrinology       Date:  2003-05       Impact factor: 4.736

10.  Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha.

Authors:  Sudha Warrier Mitra; Elena Hoskin; Joel Yudkovitz; Lisset Pear; Hilary A Wilkinson; Shinji Hayashi; Donald W Pfaff; Sonoko Ogawa; Susan P Rohrer; James M Schaeffer; Bruce S McEwen; Stephen E Alves
Journal:  Endocrinology       Date:  2003-05       Impact factor: 4.736

View more
  15 in total

1.  Regional differences in estradiol effects on numbers of HSD2-containing neurons in the nucleus of the solitary tract of rats.

Authors:  Liming Fan; Courtney E Smith; Kathleen S Curtis
Journal:  Brain Res       Date:  2010-08-20       Impact factor: 3.252

2.  Distribution and chemical composition of estrogen receptor β neurons in the paraventricular nucleus of the female and male mouse hypothalamus.

Authors:  Mario G Oyola; Maranda K Thompson; Aaron Z Handa; Robert J Handa
Journal:  J Comp Neurol       Date:  2017-08-21       Impact factor: 3.215

3.  Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance.

Authors:  Guo Zhang; Hua Bai; Hai Zhang; Camin Dean; Qiang Wu; Juxue Li; Sara Guariglia; Qingyuan Meng; Dongsheng Cai
Journal:  Neuron       Date:  2011-02-10       Impact factor: 17.173

4.  Body, metabolic and renal changes following cross-sex estrogen/progestogen therapy in a rodent model simulating its use by transwomen.

Authors:  J V Gusmão-Silva; D C K Lichtenecker; L G A Ferreira; Í Gois; R Argeri; G N Gomes; M R Dias-da-Silva
Journal:  J Endocrinol Invest       Date:  2022-06-11       Impact factor: 5.467

5.  Vasopressin-Induced Hyponatremia in Patients With Aneurysmal Subarachnoid Hemorrhage: A Case Series and Literature Review.

Authors:  Hilamber Subba; Richard R Riker; Susan Dunn; David J Gagnon
Journal:  J Pharm Pract       Date:  2021-10-21

6.  Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study.

Authors:  Charles X Kim; Kent R Bailey; George G Klee; Allison A Ellington; Guanghui Liu; Thomas H Mosley; Hamid Rehman; Iftikhar J Kullo
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

7.  Differential effects of estradiol on drinking by ovariectomized rats in response to hypertonic NaCl or isoproterenol: Implications for hyper- vs. hypo-osmotic stimuli for water intake.

Authors:  Alexis B Jones; Kathleen S Curtis
Journal:  Physiol Behav       Date:  2009-07-16

8.  Sex Differences in the Regulation of Vasopressin and Oxytocin Secretion in Bile Duct Ligated Rats.

Authors:  Kirthikaa Balapattabi; Joel T Little; Martha E Bachelor; Rebecca L Cunningham; J Thomas Cunningham
Journal:  Neuroendocrinology       Date:  2020-04-24       Impact factor: 4.914

9.  17Beta-estradiol regulation of the mRNA expression of T-type calcium channel subunits: role of estrogen receptor alpha and estrogen receptor beta.

Authors:  Martha A Bosch; Jingwen Hou; Yuan Fang; Martin J Kelly; Oline K Rønnekleiv
Journal:  J Comp Neurol       Date:  2009-01-20       Impact factor: 3.215

10.  Bisphenol, npcRNAs and Utero-Ovarian Feed-Back Control of Breast Cancer Chemosensitivity.

Authors:  Aysegul Yarpuzlu
Journal:  Environ Health Perspect       Date:  2009-08       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.